Mediclinic International Plc

Public consensus   -   Last updated 08/10/20

Reporting currency: GBP
Reporting unit: Absolute
 
NO. OF
FORECASTS
FY23
CONSENSUS
08/10/20
FY23
MIN
FY23
MAX
Hirslanden (CHF'm) - Adjusted
Revenue
7
1,869
1,771
1,955
EBITDA
7
314
294
328
EBITDA margin (%)
7
16.8
15.7
17.7
Average FX rate GBP/CHF
7
1.21
1.17
1.25
Southern Africa (ZAR'm) - Adjusted
Revenue
7
18,988
18,055
19,653
EBITDA
7
3,844
3,639
4,064
EBITDA margin (%)
7
20.2
19.8
20.8
Average FX rate GBP/ZAR
7
22.07
21.00
24.72
Middle East (AED'm) - Adjusted
Revenue
7
3,903
3,477
4,538
EBITDA
7
648
546
747
EBITDA margin (%)
7
16.6
15.7
17.3
Average FX rate GBP/AED
7
4.70
4.59
4.84
Adjusted Group (GBP'm)
Revenue
7
3,233
2,967
3,479
EBITDA
7
569
522
617
EBITDA margin (%)
7
17.6
16.9
18.0
Operating profit
7
344
316
386
Earnings per share (pence)
7
27.9
26.6
31.2
Dividend per share (pence)
6
7.0
3.0
8.5
Net Debt
6
1,821
1,496
1,971
Net cash generated from operating activities
6
406
236
460
Total Group Capex
7
215
195
253

Disclaimer

Mediclinic International plc (“Mediclinic”) does not endorse or adopt any of the consensus estimates expressed in this report. The report represents the views of analysts from which the consensus estimates are derived. Mediclinic will not provide any commentary on the consensus or answer questions on it. The circulation of the consensus by Mediclinic is not mandatory and Mediclinic may amend its practice on this at any time.